sleep disorder

Advertisement

cGxPJobs Banner

Alkermes Reports Strong Phase 2 Data for Narcolepsy Drug

DUBLIN, April 16, 2026 Alkermes plc has announced new data from its Vibrance-1 Phase 2 clinical study of alixorexton,...

By cGxPwire Editor
April 17, 2026

Read More

Advertisement

cGxPJobs

Directory